Abstract
Purpose:
This study is to test the feasibility of optical coherence tomography (OCT) detection of photoreceptor abnormality and to verify the photoreceptor abnormality is rod predominated in early DR.
Methods:
OCT images were acquired from normal eyes, diabetic eyes with no diabetic retinopathy (NoDR) and mild NPDR. Quantitative features, including thickness measurements quantifying band distances and reflectance intensity features among the external limiting membrane (ELM), inner segment ellipsoid (ISe), interdigitation zone (IZ) and retinal pigment epithelium (RPE) were determined. Comparative OCT analysis of central fovea, parafovea and perifovea were implemented to verify the photoreceptor abnormality is rod predominated in early DR.
Results:
Thickness abnormalities between the ISe and IZ also showed a decreasing trend among cohorts. Reflectance abnormalities of the ELM, IZ and ISe were observed between healthy, NoDR, and mild NPDR eyes. The normalized ISe/RPE intensity ratio revealed a significant decreasing trend in the perifovea, but no detectable difference in central fovea.
Conclusions:
Quantitative OCT analysis consistently revealed outer retina, i.e., photoreceptor, changes in diabetic patients with NoDR and mild NPDR. Comparative analysis of central fovea, parafovea and perifovea confirmed the photoreceptor abnormality is rod predominated in early DR.
Keywords: optical coherence tomography, medical imaging, ophthalmology, diabetic retinopathy, neurodegeneration, macular, optical diagnostics for medicine, physiology, visual system, noninvasive assessment
Summary Statement:
Quantitative optical coherence tomography features were used to explore photoreceptor changes in early diabetic retinopathy. The inner segment ellipsoid and retinal pigment epithelium intensity ratio was the most sensitive parameter, and the perifovea was the most sensitive region, which suggests rod abnormalities in early diabetic retinopathy.
Introduction
Diabetic retinopathy (DR) is the leading cause of blindness in working age adults and is predicted to significantly increase in prevalence worldwide1. The number of people affected by diabetes mellitus (DM) is predicted to reach 552 million2 and nearly 45% of DM patients may develop DR associated vision impairments3. Typically, the early stages of DR progress asymptomatically until the patient’s vision is affected, however by this time the condition may be irreversible4. Therefore, early detection of DR is of the utmost importance to enable prompt treatment to prevent vision loss.
DR encompasses both retinal vascular and neural aspects. Previous studies have demonstrated the close correlation between retinal vascular abnormalities and DR severity5, 6, and quantitative vascular features of non-proliferative DR (NPDR) have been validated for computer aided DR staging7, 8. Recent studies have also reported early retinal neurodegeneration in DR9–11. Moreover, electrophysiological features have provided evidence for photoreceptor changes in patients with diabetic retinopathy (DR)12, 13, suggesting that outer retinal alterations may be observed in optical coherence tomography (OCT).
OCT has enabled depth-resolved visualization of outer retinal changes, especially the external limiting membrane (ELM), photoreceptor inner segment ellipsoid (ISe), and retinal pigment epithelium (RPE), as representative of photoreceptor status. ISe integrity has been demonstrated to affect visual acuity (VA) in retinal degenerative diseases14, 15. Stimulus-evoked ISe change has been also reported to reflect metabolic function of retinal photoreceptor16. The ELM is also considered as a biomarker of photoreceptor integrity and could be an important predictor of visual function in DR17. Although previous studies have revealed the outer retinal features as a DR predictor, these studies were limited to qualitative evaluation of ELM or ISe disruption, measuring outer retinal thickness changes and no consideration for early DR18. We hypothesize that early subtle photoreceptor abnormalities can be quantified using OCT feature analysis. In this study, we evaluate outer retinal band features, thickness, and reflectance, to reveal early photoreceptor changes in early stages of DR.
Methods
This is a cross-sectional OCT study evaluating DR biomarkers in patients with diabetes mellitus. Patients with a history of no DR (NoDR) or mild NPDR were recruited from the University of Illinois at Chicago (UIC) Retinal Clinic. This study was conducted in accordance with the ethical standards stated in the Declaration of Helsinki and approved by the institutional review board of the University of Illinois at Chicago. The inclusion criteria included subjects 18 years of age or older with a diagnosis of Type II diabetes mellitus. Exclusion criteria included presence of macular edema, NPDR higher than mild NPDR prior vitrectomy surgery, history of other ocular diseases other than cataracts or mild refractive error, and ungradable OCT images. All patients underwent a complete anterior segment slit lamp examination and dilated ophthalmoscopy using both the biomicroscope and indirect ophthalmoscopy. The patients were classified as having NoDR or mild NPDR according to the Early Treatment Diabetic Retinopathy Study staging system (ETDRS) by a retina specialist (J.I.L.)19.
All patients underwent OCT imaging using spectral-domain OCT (ANGIOVUE spectral domain OCTA system; Optovue, Fremont, CA), with a wavelength of 850 nm, 70-kHz A-scan rate, an axial and lateral resolution of 5 and 15 μm, respectively 6 × 6 mm volumetric scan centered at the macula, for a total of either 304 or 400 B-scans, were acquired. All the images were quantitatively examined, and OCT images with severe motion or signal loss were also excluded. OCT volumes were exported into a custom-developed MATLAB (Mathworks, Natick, MA) software for further outer retinal analysis.
Quantitative OCT Analysis
Retinal regions for analysis were selected using OCT B-scans centered at the fovea, selection of points between 1.25 and 2.5 mm and 2.5 and 5.5 mm away from the center of the fovea were defined as parafoveal and perifoveal area, respectively (Fig. 1(a)).
Figure 1.

A) Representative OCT B-scan of healthy control subject, the dashed white lines are representative eccentricities for A-line analysis. The colored markers are representative retinal locations, the corresponding band location is summarized in the legend. B) Representative averaged A-line profile of the perifovea to illustrate individual retinal locations and outer retina thickness measurements. ILM: inner limiting membrane; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer; ELM: external limiting membrane; ISe: inner segment ellipsoid; IZ: interdigitation zone; RPE: retinal pigment epithelium; T1: first hyporeflective trough, T2: second hyporeflective trough. D12: distance from the ELM to ISe, D13: distance from the ELM to IZ, D23: distance from the ISe to IZ, and D14: distance from the ELM to RPE. D1T1: distance from the ELM to T1, D1T2: distance from the ELM to T2. The scale bar represents 0.5 mm.
A-lines were adjusted from selected areas to match each retinal layer in same horizontal position and averaged, inner limiting membrane (ILM), external limiting membrane (ELM), inner segment ellipsoid (ISe), interdigitation zone (IZ), retinal pigment epithelium (RPE) peaks, and the first and second hyporeflective troughs (T1 and T2) were manually detected (Fig. 1(b)). In this study, we measured the thickness of six photoreceptor locations. L12, L23, L34, L13, DT1, and DT2. Where L12 quantifies the distance between the ELM to ISe, L23 measures the distance from the ISe to IZ, L34 measures the distance from IZ to RPE, and L13 measures the distance from ELM to IZ. DT1 and DT2 measures the distance from the ELM to the first and second hyporeflective troughs, respectively. Examples of thickness measurements are illustrated in Fig. 1(b). Concurrently, the reflectance intensities of the ELM, ISe, IZ, and RPE were measured from the parafovea and perifovea retina. To reduce noise, the reflectance values were normalized to the inner plexiform layer (IPL) intensity. Additionally, we evaluated the ratio between the ISe and RPE intensity. At the central fovea, the boundary of the IPL cannot be determined, therefore intensity features at the central retina were not analyzed. Each feature was sampled from 10 adjacent A-lines in each retinal region, central fovea, parafovea and perifovea, and the average value was reported.
Statistical analyses
Statistical analysis was performed using OriginPro (OriginLab, Northampton, MA, USA). All features were analyzed for normality using the Shapiro-Wilk test. If the feature was normally distributed, multiple group comparisons were performed using a one-way ANOVA test, and the individual pairwise comparisons were performed using an unpaired Student’s t-test. If the feature was not normally distributed, a Kruskal-Wallis one-way ANOVA was performed, and the individual pairwise comparisons were performed using a Mann-Whitney t-test. For this study, a P value of <0.05 was considered statistically significant.
Results
The image database used in this study included 14 control subjects (21 eyes), 31 diabetic patients (20 NoDR eyes and 21 Mild NPDR eyes), staged according to the ETDRS staging system19. No statistically significant differences were observed among the controls, and diabetic eyes with respect to age, sex, hypertension, or duration of diabetes (analysis of variance [ANOVA], P = 0.69, chi-square test, P = 0.85). Furthermore, no significance in hypertension or insulin dependence among the diabetic groups was observed. A summary of the subject demographics used in this study are presented in Table 1.
Table 1.
Demographics of human subjects
| Control | NoDR | Mild NPDR | |
|---|---|---|---|
| No. of subjects | 14 | 14 | 17 |
| Sex (male) | 8 | 5 | 7 |
| Age (mean ± SD), years | 56.60 ± 14.07 | 62.27 ± 10.51 | 59.53 ± 11.87 |
| Age range, years | 37–80 | 47–80 | 24–74 |
| Duration of diabetes (mean ± SD), years | - | 8.89 ± 5.04 | 16.73 ± 4.82 |
| Diabetes type (%, Type II) | - | 100 | 100 |
| Insulin dependence (Y/N) | - | 3/11 | 5/12 |
| HbA1c, % | - | 7.6 ± 2.1 | 8.3 ± 2.4 |
| HTN prevalence, % | 10 | 72 | 70 |
HbA1C = glycated hemoglobin, HTN = hypertension
In this study we quantified 11 outer retinal features, namely 6 thickness measurements, L12, L23, L34, L13, DT1 and DT2, and 5 intensity features of the ELM, ISe, IZ, RPE, and ISe/RPE ratio. Examples of averaged A-line intensity plots in the central fovea, parafovea and perifovea for healthy controls, NoDR and Mild NPDR eyes are illustrated in Figure 2. Qualitative observations of the example A-line intensity plots suggest an overall decreasing ISe intensity trend can be observed from control to Mild NPDR eyes, whereas increasing in RPE intensity. Qualitative observations of thickness changes between cohorts did not reveal a discernable trend, therefore quantitative feature analysis of thickness and intensity was performed.
Figure 2.

Representative reflectance profiles at central fovea, parafoveal, and perifoveal regions. A-B are from control subjects, C-D are from NoDR patients, and E-F are from Mild NPDR patients. ELM: external limiting membrane; ISe: inner segment ellipsoid; IZ: interdigitation zone; RPE: retinal pigment epithelium, T1: hyporeflective trough 1; T2: hyporeflective trough 2.
For the thickness measurements, significant differences were observed for the L23 thickness between mild NPDR and control eyes in the central fovea (Mann-Whitney t-test, p=0.005), parafovea (Mann-Whitney t-test, p=0.044) and perifovea (Mann-Whitney t-test, p=0.036). Significant differences were also observed for the L23 thickness between NoDR and mild NPDR in the perifovea (Mann-Whitney t-test, p=0.039). Overall, the decreasing trend from no retinopathy to retinopathy can be seen in all three retinal eccentricities. The other thickness measurements did not reveal consistent statistically significant differences. All photoreceptor thickness measurements are summarized in table 2.
Table 2.
Quantitative analysis of OCT thickness measurements
| P | |||||||
|---|---|---|---|---|---|---|---|
| Features | Control | NoDR | Mild | I vs II | I vs III | II vs III | ANOVA |
| L12 (μm) | |||||||
| Central | 30.57 ± 2.04 | 32.14 ± 4.15 | 31.80 ± 3.69 | 0.253 | 0.400 | 0.795 | 0.488 |
| Parafovea | 25.86 ± 2.41 | 24.86 ± 2.48 | 24.60 ± 2.68 | 0.286 | 0.126 | 0.724 | 0.270 |
| Perifovea | 23.00 ± 2.57 | 22.07 ± 2.79 | 22.80 ± 2.26 | 0.350 | 0.841 | 0.420 | 0.589 |
| L13 (μm) | |||||||
| Central | 70.71 ± 3.74 | 71.57 ± 3.50 | 68.40 ± 5.02 | 0.650 | 0.074 | 0.040 | 0.072 |
| Parafovea | 51.86 ± 4.46 | 50.36 ± 3.75 | 47.55 ± 5.44 | 0.298 | 0.011 | 0.094 | 0.024 |
| Perifovea | 46.00 ± 3.59 | 45.43 ± 4.54 | 43.80 ± 4.50 | 0.627 | 0.030 | 0.251 | 0.103 |
| L23 (μm) | |||||||
| Central | 40.14 ± 3.21 | 39.43 ± 4.54 | 36.60 ± 3.84 | 0.651 | 0.005 | 0.065 | 0.017 |
| Parafovea | 26.00 ± 3.05 | 25.50 ± 2.28 | 22.95 ± 4.89 | 0.711 | 0.044 | 0.111 | 0.086 |
| Perifovea | 23.00 ± 2.74 | 23.36 ± 2.92 | 21.00 ± 3.64 | 0.943 | 0.036 | 0.039 | 0.049 |
| L14 (μm) | |||||||
| Central | 13.29 ± 2.94 | 13.07 ± 1.90 | 15.00 ± 2.58 | 0.651 | 0.070 | 0.021 | 0.047 |
| Parafovea | 16.43 ± 3.50 | 14.79 ± 2.49 | 16.20 ± 3.82 | 0.148 | 0.795 | 0.248 | 0.319 |
| Perifovea | 17.14 ± 3.17 | 15.21 ± 3.21 | 16.50 ± 5.20 | 0.094 | 0.453 | 0.495 | 0.286 |
| DT1 (μm) | |||||||
| Central | 12.86 ± 2.35 | 13.93 ± 3.02 | 13.20 ± 3.14 | 0.240 | 0.614 | 0.482 | 0.488 |
| Parafovea | 10.43 ± 2.44 | 10.07 ± 1.90 | 10.35 ± 2.28 | 0.713 | 0.989 | 0.715 | 0.911 |
| Perifovea | 8.86 ± 2.59 | 8.14 ± 1.83 | 8.55 ± 2.01 | 0.325 | 0.592 | 0.582 | 0.582 |
| DT2 (μm) | |||||||
| Central | 47.57 ± 2.73 | 49.29 ± 4.66 | 48.75 ± 5.04 | 0.379 | 0.773 | 0.639 | 0.708 |
| Parafovea | 36.57 ± 3.09 | 35.14 ± 2.98 | 34.65 ± 3.15 | 0.161 | 0.056 | 0.611 | 0.122 |
| Perifovea | 32.71 ± 2.67 | 31.71 ± 3.27 | 32.10 ± 2.77 | 0.371 | 0.283 | 0.883 | 0.496 |
All values are presented as mean ± SD. Columns 5–7 are pairwise comparisons, and column 8 are multiple group comparisons. Kruskal-Wallis was used for multiple comparisons, One-versus-one comparisons were conducted using Mann-Whitney t test.
For the intensity features, the ELM intensity revealed statistically significant differences in the perifovea region between NoDR and control eyes (Student’s t-test, p=0.011), and NoDR and mild NPDR eyes (Student’s t-test, p=0.001). The IZ intensity revealed statistically significant differences between cohorts in the perifovea region between mild NPDR and control eyes (Student’s t-test, p=0.038) and NoDR and mild NPDR eyes (Student’s t-test, p=0.005). The ISe intensity features revealed statistically significant differences in the perifovea region between mild NPDR and control eyes (Student’s t-test, p=0.001) and NoDR and mild NPDR eyes (Student’s t-test, p=0.001). Overall, the trend for ISe intensity decreases with disease progression. Whereas RPE intensity features revealed an increasing trend with disease progression. Since we observed an opposing trend between ISe and RPE intensity, to further highlight differences we took the ISe/RPE intensity ratio. The ISe/RPE ratio revealed a clear decreasing trend with disease progression. There were statistically significant differences between all stages in the perifovea region (Student’s t-test, p<0.05). However, there was no detectable difference in the central fovea. All intensity features are summarized in table 3.
Table 3.
Quantitative analysis of OCT intensity features
| P | |||||||
|---|---|---|---|---|---|---|---|
| Features | Control (I) | NoDR (II) | Mild (III) | I vs II | I vs III | II vs III | ANOVA |
| ELM | |||||||
| Parafovea | 0.861 ± 0.054 | 0.885 ± 0.042 | 0.882 ± 0.029 | 0.151 | 0.134 | 0.807 | 0.192* |
| Perifovea | 0.839 ± 0.044 | 0.879 ± 0.042 | 0.829 ± 0.038 | 0.011 | 0.428 | 0.001 | 0.003* |
| ISe | |||||||
| Parafovea | 1.375 ± 0.064 | 1.386 ± 0.085 | 1.339 ± 0.060 | 0.688 | 0.065 | 0.086 | 0.102* |
| Perifovea | 1.371 ± 0.071 | 1.383 ± 0.065 | 1.294 ± 0.065 | 0.627 | 0.001 | 0.001 | <0.001* |
| IZ | |||||||
| Parafovea | 1.357 ± 0.085 | 1.405 ± 0.113 | 1.320 ± 0.093 | 0.191 | 0.185 | 0.028 | 0.045* |
| Perifovea | 1.339 ± 0.072 | 1.371 ± 0.078 | 1.288 ± 0.080 | 0.229 | 0.038 | 0.005 | 0.009* |
| RPE | |||||||
| Parafovea | 1.336 ± 0.061 | 1.378 ± 0.054 | 1.395 ± 0.061 | 0.042 | 0.003 | 0.382 | 0.008* |
| Perifovea | 1.338 ± 0.050 | 1.396 ± 0.059 | 1.353 ± 0.074 | 0.007 | 0.397 | 0.066 | 0.025† |
| ISe/RPE | |||||||
| Central | 0.845 ± 0.069 | 0.827 ± 0.046 | 0.845 ± 0.036 | 0.375 | 0.993 | 0.251 | 0.575* |
| Parafovea | 1.030 ± 0.041 | 1.007 ± 0.059 | 0.961 ± 0.049 | 0.209 | <0.001 | 0.024 | <0.001* |
| Perifovea | 1.025 ± 0.040 | 0.992 ± 0.051 | 0.958 ± 0.040 | 0.049 | <0.001 | 0.049 | <0.001* |
All values are presented as mean ± SD. Columns 5–7 are pairwise comparisons, and column 8 are multiple group comparisons. If one-way ANOVA was used for multiple comparisons, One-versus-one comparisons were conducted using Student’s t test. If Kruskal-Wallis was used for multiple comparisons, One-versus-one comparisons were conducted using Mann-Whitney t test.
One-way ANOVA
Kruskal-Wallis
Discussion
In summary, we evaluated outer retina alternations in early-stage DR using OCT photoreceptor thickness and intensity features using clinical OCT. Namely we measured the thickness of the hyperreflective bands, L12, L23, L34, L13, and hypo-reflective troughs, DT1, and DT2, and the intensity of the hyperreflective bands in the central fovea, parafovea, and perifovea. The result of this study suggests that there may be metabolic abnormalities that occur in early DR, due to thickness and intensity changes associated with the ISe.
Previous OCT studies have primarily measured retinal thickness changes in DR. Goebel et al., evaluated retinal thickness in the parafovea retina and reported significant increase in the retinal thickness of diabetic eyes compared to healthy controls18. However, that study was limited by absence of inclusion of analysis of DR stages, particularly NoDR and Mild NPDR. In contrast, a study by Vujosevic et al., which performed retinal thickness measurements for healthy controls, NoDR, and NPDR groups reported no statistical differences in the outer retinal thickness20. Similarly, Dimitrova et al. compared the differences in the outer retinal thickness of healthy controls and NoDR cohorts and reported no significant differences among the groups21. A recent study by McAnany et al. performed an analysis of the outer retinal thickness for healthy controls, NoDR, and mild NPDR cohorts22. In these studies, there may be discrepancies in how they measure the outer retinal thickness. For instance, McAnany et al. determined the outer retina thickness as the boundary between the inner nuclear layer and the outer plexiform layer, which may dilute the subtle thickness changes of the individual retinal bands. In these studies, the evaluation of OCT inner and outer retinal thicknesses alone may not provide the sensitivity for detection of early DR.
Further evaluation of individual retinal layers may provide better sensitivity for detection in DR. For the inner retina, Van Dijk et al. found a selective loss of inner retinal layer thickness in type I diabetic patients with minimal DR23. In a follow up study, they reported a statistically significant difference in paracentral the ganglion cell layer and corresponding loss of the RNFL was a significant biomarker in a study of type I diabetes compared to controls24. Whereas for the outer retina, Mohammed et al. used the probability density function to evaluate the thickness of the retinal layers by OCT in diabetics in various stages of retinopathy. They found that the outer plexiform layer was the most discriminative for classifying normal and diabetic patients with NPDR25. In a cross sectional study, Ozkaya et al. showed that the photoreceptor outer segment in the foveal center was thinner in patients with clinical retinopathy compared to normal subjects and diabetics without retinopathy26. Yao et al. demonstrated the effect of retinal eccentricity on the thickness measurement of individual outer retina bands27. Therefore, in this study we similarly measured the individual outer retina bands, for the central fovea, parafovea, and perifovea, respectively. The observation in this study suggests that there is a subtle decrease in thickness with DR stage progression between the ISe and IZ bands.
Clinically, DR has been defined as a microvascular disease. Therefore, recent endeavors for early detection and objective classification of DR have primarily explored the retinal vasculature for the detection of early-stage DR using OCTA7, 8, 21, 28. However, there is a growing body of evidence that suggests that the photoreceptor cells play a role in the development of early stages of DR29. The photoreceptor layer is known to be the most metabolically demanding section of the cells in the retina, consuming more than 75% oxygen of the retina30, 31. Oxidative stress has been known to play a central role in the complications of diabetes32. In relation to the cellular level, mitochondrial DNA is highly susceptible to oxidative damage33. Previous studies has shown that elevated levels of superoxides in the retina induces mitochondrial dysfunction34. Therefore, to assess retina function, it is crucial to quantify the intensity changes of the photoreceptor layer. The photoreceptor contains more than 75% of the retinal mitochondria, and the ISe is the main location of the photoreceptor mitochondria31. Therefore, the ISe may represent the metabolic activities of the photoreceptors16, 35. While both the ELM and RPE are not neuronal cells, studies have shown that they do indicate the integrity of the photoreceptor17. Recent studies have suggested alterations of the RPE in diabetes, in particular electron microscopy experiments have reported ultrastructural changes in early stage DR36.
To evaluate retinal function, recent studies have also explored the correlation between different imaging modalities and clinical features. Srinivasan et al. evaluated the correlation between retinal structure and function using modalities such as OCTA, multifocal electroretinogram (mfERG) and contrast sensitivity (CS) among diabetic patients with and without retinopathy37. In their mfERG analysis, they reported significant differences in P1 implicit times were observed between NoDR and NPDR, and that P1 implicit times were significantly correlated with retinal perfusion. Similarly, Sener et al. evaluated the correlation between OCTA and mfERG in DM patients38. They report that there were decreased amplitudes of mfERG waves, N1 and P1 in the circles of 2 and 5 degrees. In their correlation analysis, they reported that the N1 and P1 amplitudes were correlated to the vascular density changes in the parafovea and perifovea regions. McAnany et al. evaluated contrast sensitivity, outer retina thickness in OCT and visual acuity measurements13. In their study, they reported that VA did not reveal significant differences between NoDR and NPDR groups, and that VA did not correlate with the outer retinal thickness changes in NoDR and NPDR. Similarly, Srinivasan et al. reported no significant differences between the logMAR between NoDR and NPDR37. However, they did report that logMAR was significantly correlated with central subfoveal thickness (CST) in both NoDR and NPDR. These studies suggest that functional changes might occur in early DR, however, clinical features such as VA may not be sensitive for early DR detection. Better developments of quantitative imaging features, which may provide the sensitivity for early detection of DR, is desirable.
In this study, we assessed the reflectance intensity changes of the ELM, ISe, IZ and RPE, and derived the ISe/RPE intensity ratio to evaluate photoreceptor abnormalities. The observations in this study suggest that the ISe intensity decreases with increased progression of early DR. A study by Toprak et al., similarly, observed a decrease in ISe intensity in mild NPDR as compared to healthy eyes10. Furthermore, we observed an increasing trend for the RPE intensity with increasing severity. Therefore, the relationship between two features with polarizing trends, the ISe/RPE intensity ratio, may enhance the subtle ISe and RPE abnormalities that occur in early DR. Significant differences in the ISe/RPE intensity ratio was observed in the parafovea and perifovea regions. However, there were no significant differences in the central fovea. Since the parafovea and perifovea regions are primarily rod dominated, the observation in this study suggests rod abnormalities in early DR.
This study did have a few limitations, namely our sample size was modest for each cohort, and all the OCT data were acquired from one imaging device (ANGIOVUE spectral domain OCTA system) in a single location. For future study, we plan to expand the population and evaluate OCT data from different devices (e.g., Spectralis, Cirrus, etc.).
In conclusion, quantitative OCT analysis consistently revealed photoreceptor abnormality in diabetic patients with NoDR and mild NPDR. The normalized ISe/RPE intensity ratio of perifoveal OCT is the most sensitive feature to differentiate all three cohorts. Comparative analysis of central fovea, parafovea and perifovea confirmed the photoreceptor abnormality is rod predominated in early DR.
Funding:
This research was supported in part by National Institutes of Health (NIH) (R01 EY023522, R01 EY029673, R01 EY030101, R01 EY030842, P30 EY001792); Richard and Loan Hill endowment; Unrestricted grant from Research to prevent blindness; T32 Institutional Training Grant for a training program in the biology and translational research on Alzheimer’s disease and related dementias (T32AG057468).
Footnotes
Disclosures
The authors declare that there are no conflicts of interest related to this article.
References
- 1.Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes care. 2004; 27:s84–s7. [DOI] [PubMed] [Google Scholar]
- 2.Ikram MK, Cheung CY, Lorenzi M, et al. Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes care. 2013; 36:750–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Alam M, Toslak D, Lim JI, Yao X. OCT feature analysis guided artery-vein differentiation in OCTA. Biomedical optics express. 2019; 10:2055–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ellis D, Burgess P, Kayange P. ‘Teaching corner’: Management of Diabetic Retinopathy. Malawi Medical Journal. 2013; 25:116–20. [PMC free article] [PubMed] [Google Scholar]
- 5.Nguyen TT, Wong TY. Retinal vascular changes and diabetic retinopathy. Current diabetes reports. 2009; 9:277–83. [DOI] [PubMed] [Google Scholar]
- 6.Nayak J, Bhat PS, Acharya R, et al. Automated identification of diabetic retinopathy stages using digital fundus images. Journal of medical systems. 2008; 32:107–15. [DOI] [PubMed] [Google Scholar]
- 7.Alam M, Zhang Y, Lim JI, et al. Quantitative optical coherence tomography angiography features for objective classification and staging of diabetic retinopathy. Retina. 2020; 40:322–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Le D, Alam M, Miao BA, et al. Fully automated geometric feature analysis in optical coherence tomography angiography for objective classification of diabetic retinopathy. Biomedical optics express. 2019; 10:2493–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wanek J, Blair NP, Chau FY, et al. Alterations in retinal layer thickness and reflectance at different stages of diabetic retinopathy by en face optical coherence tomography. Investigative ophthalmology & visual science. 2016; 57:OCT341–OCT7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Toprak I, Yildirim C, Yaylali V. Impaired photoreceptor inner segment ellipsoid layer reflectivity in mild diabetic retinopathy. Canadian Journal of Ophthalmology. 2015; 50:438–41. [DOI] [PubMed] [Google Scholar]
- 11.Ahuja S, Saxena S, Meyer CH, et al. Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy. International journal of retina and vitreous. 2018; 4:1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Holopigian K, Greenstein VC, Seiple W, et al. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997; 38:2355–65. [PubMed] [Google Scholar]
- 13.McAnany JJ, Park JC. Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram. Invest Ophthalmol Vis Sci. 2019; 60:64–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Saxena S, Srivastav K, Cheung CM, et al. Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography. Clinical Ophthalmology (Auckland, NZ). 2014; 8:2507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Rangaraju L, Jiang X, McAnany JJ, et al. Association between visual acuity and retinal layer metrics in diabetics with and without macular edema. Journal of Ophthalmology. 2018; 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ma G, Son T, Kim TH, Yao X. In vivo optoretinography of phototransduction activation and energy metabolism in retinal photoreceptors. J Biophotonics. 2021:e202000462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Karim M, Mohamed S, Nabil K. External limiting membrane and ellipsoid zone integrity and presenting visual acuity in treatment-naive center involved diabetic macular edema. EC Ophthalmol. 2018; 9:408–21. [Google Scholar]
- 18.Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina. 2002; 22:759–67. [DOI] [PubMed] [Google Scholar]
- 19.Group ER. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. Ophthalmology. 1991; 98:741–56. [DOI] [PubMed] [Google Scholar]
- 20.Vujosevic S, Midena E. Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations. Journal of diabetes research. 2013; 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dimitrova G, Chihara E, Takahashi H, et al. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. Investigative ophthalmology & visual science. 2017; 58:190–6. [DOI] [PubMed] [Google Scholar]
- 22.Park JC, Chen Y-F, Liu M, et al. Structural and functional abnormalities in early-stage diabetic retinopathy. Current eye research. 2020; 45:975–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Van Dijk HW, Kok PH, et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Investigative ophthalmology & visual science. 2009; 50:3404–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Van Dijk HW, Verbraak FD, Kok PH, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Investigative ophthalmology & visual science. 2010; 51:3660–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mohammed S, Li T, Chen XD, et al. Density-based classification in diabetic retinopathy through thickness of retinal layers from optical coherence tomography. Scientific Reports. 2020; 10:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ozkaya A, Alkin Z, Karakucuk Y, et al. Thickness of the retinal photoreceptor outer segment layer in healthy volunteers and in patients with diabetes mellitus without retinopathy, diabetic retinopathy, or diabetic macular edema. Saudi Journal of Ophthalmology. 2017; 31:69–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yao X, Son T, Kim T-H, Le D. Interpretation of anatomic correlates of outer retinal bands in optical coherence tomography. Experimental Biology and Medicine. 2021:15353702211022674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Alam M, Lim J, Yao X. Vascular complexity analysis in optical coherence tomography angiography of diabetic retinopathy. Retina (Philadelphia, Pa). 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Du Y, Veenstra A, Palczewski K, Kern TS. Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proceedings of the National Academy of Sciences. 2013; 110:16586–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Narayan DS, Chidlow G, Wood JP, Casson RJ. Glucose metabolism in mammalian photoreceptor inner and outer segments. Clinical & experimental ophthalmology. 2017; 45:730–41. [DOI] [PubMed] [Google Scholar]
- 31.Miller DJ, Cascio MA, Rosca MG. Diabetic retinopathy: the role of mitochondria in the neural retina and microvascular disease. Antioxidants. 2020; 9:905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation research. 2010; 107:1058–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Green DR, Amarante-Mendes GP. The point of no return: mitochondria, caspases, and the commitment to cell death. Apoptosis: Mechanisms and Role in Disease: Springer; 1998. p. 45–61. [DOI] [PubMed] [Google Scholar]
- 34.Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxidants & redox signaling. 2005; 7:1581. [DOI] [PubMed] [Google Scholar]
- 35.Kim T-H, Ding J and Yao X. Intrinsic signal optoretinography of dark adaptation kinetics. Sci Rep-Uk 2022; 12:2475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium. The Histochemical Journal. 1993; 25:648–63. [DOI] [PubMed] [Google Scholar]
- 37.Srinivasan S, Sivaprasad S, Rajalakshmi R, et al. Retinal structure–function correlation in type 2 diabetes. Eye. 2021:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sener H, Sevim DG, Oner A, Erkilic K. Correlation between optical coherence tomography angiography and multifocal electroretinogram findings in patients with diabetes mellitus. Photodiagnosis and Photodynamic Therapy. 2021; 36:102558. [DOI] [PubMed] [Google Scholar]
